To evaluate the hypothalamic contribution to the development of anterior pituitary (AP) 
Introduction
The anterior pituitary is a highly heterogeneous organ composed of a variety of cells located throughout the gland. The process by which the individual secretory cells differentiate and proliferate during development is largely unknown. Considerable progress has been made in understanding the role played by transcription factors, but we still know relatively little about the input of the foetal hypothalamus in pituitary cell development. After birth, hypothalamic factors are critical in regulating anterior pituitary (AP) function, but the role played before birth remains largely unknown.
Recent studies suggest that the timely expression of various transcription factors is wholly responsible for the composition of the AP, independent of the hypothalamus (Dasen & Rosenfeld, 1999; Melmed, 2003) . A number of experiments in genetically engineered mice are consistent with this view. For example, corticotrophinreleasing hormone (CRH) receptor knockout mice (Timpl et al., 1998) . and thyrotrophinreleasing hormone (TRH) knockout mice have a normal complement of all pituitary cells (Shibusawa et al., 2000) , clearly suggesting that these two hypothalamic factors are not required for normal development of the AP.
On the other hand, numerous other studies of the actions of various hypothalamic factors, including TRH, on differentiation and proliferation of AP cells would clearly suggest a potential role in AP development. For example, in cultured adult rat somatotrophs, GH-releasing hormone (GHRH) stimulates somatotroph proliferation (Billestrup et al., 1986) . Similarly, in cultured foetal cells, TRH induces thyrotroph differentiation (Hertier & Dubois, 1993) and in pituitary primordial, gonadotropinreleasing hormone (GnRH) effectively stimulates the responsiveness of gonadotrophs during early pituitary differentiation (Kudo et al., 1994) . Together, these studies suggest a high likelihood that hypothalamic trophic factors are important for determining the development of pituitary cells during foetal life.
The present study was therefore aimed at assessing the contribution of hypothalamic input on the development of pituitary cells in vivo by measuring the effects of total removal of hypothalamic input through the functional disconnection of the pituitary from the hypothalamus by surgery in late gestational foetal sheep.
Hypothalamo-pituitary disconnection, HPD, was performed at 110 days (d) gestation, representing a time many hypothalamic factors are expressed and there is a patent hypophysial portal system (Levidiotis et al., 1991) . The well established HPD procedure (Antolovich et al., 1990; Canny et al., 1998; Clarke et al., 1983; Poore et al., 1999) isolates the pituitary from hypothalamic influence by severing the neural connections to the median eminence while maintaining afferent and efferent blood flow to the pituitary.
Materials and Methods

Animals and surgery
All experimental procedures were performed with prior approval from The University of Adelaide Standing Committee on Ethics in Animal Experimentation. Fixed foetal pituitary tissue from Merino ewes (singleton n=7 and twin pregnancies n=11) of known gestational age (110 or 141 d gestation; Term = 147±3 d gestation) (Houghton et al., 1997) . A total of eighteen foetal sheep pituitaries were collected.
HPD of foetal sheep (n = 6) was performed at 110 d gestation, as previously described (Antolovich et al., 1990; Clarke et al., 1983; Houghton et al., 1997) . All surgery was performed under general anesthesia using halothane (0.5-4.0%) and N 2 O:O 2 (50:50 vol/vol). Aseptic procedures were followed and halothane concentrations adjusted to maintain the appropriate level of anesthesia. The sham surgery, also performed at 110 d gestation, involved identical procedures as for HPD except that no neural tissue was removed and the hypothalamus-pituitary connection remained intact.
Pituitaries were also collected from intact un-operated foetal sheep at 110 d gestation (n=6; one foetus from twin pregnancies) for use as a gestational age control. All ewes were sacrificed using an overdose of sodium pentobarbitone (200mg/kg; Lethobarb; Virbac Pty Ltd., New South Wales, Australia) at either 110 d gestation or 141 d gestation when pituitaries were collected. All foetal sheep were delivered via laparotomy, weighed, and sacrificed by decapitation.
Confirmation of HPD
The completeness of the disconnection of the hypothalamus from the pituitary in the tissues used for this study was confirmed in all HPD foetal sheep on the basis of plasma prolactin (PRL) responses to the administration of chlorpromazine (12.5 mg iv) and TRH (50 µg iv). Basal plasma PRL concentrations were significantly lower in HPD than sham operated fetuses. HPD was further confirmed by the absence of a PRL response to chlorpromazine, and pituitary viability was confirmed by an intact PRL response to TRH. Additionally, macroscopic examination of the lesion site post mortem was used to confirm accurate and complete anatomical disconnection, (Houghton et al., 1997) .
Immunohistochemistry
All pituitaries were rapidly removed post mortem and immediately fixed in icecold 4% formaldehyde in phosphate buffered saline (PBS [0.01 M (pH 7.4) for 24 h, and embedded in paraffin. Whole pituitary glands were bisected along the coronal plane with the neurointermediate lobe kept intact. Thus, the pars intermedia and pars nervosa served as a positive control for ACTH and negative control tissue for all hormones, respectively.
Sets of serial sections were cut at 5μm thickness, with adjacent sets separated by at least Table 1 . Double-labeled immunofluorescence was performed by incubating the sections for 24 h at 4 C with a primary antibody cocktail containing: antisera against LH and FSH, as noted in Table 1, to (co)localize gonadotrophins or against LH and TSH to (co)localize LHβ and TSHβ. 
Specificity and cellular localization of immunostaining
Although the specificity of the NIDDK polyclonal anti-ovine antibodies has been well established (eg Liu et al., 2005; Sheng et al., 1998) , further assessment of the specificity of immunostaining of these pituitary hormones in the present system was accomplished with additional control procedures. These included omission of primary antibodies, replacement of the primary antibodies with 10% normal donkey serum, or incubations with primary antibodies followed by secondary antibodies produced in an inappropriate host species. We observed no immunoreactivity following any of these control procedures. We have previously confirmed specificity of immunostaining for oPRL, oTSHβ and oLHβ (Schwartz et al., 1999) and have validated the use of the mouse monoclonal anti-human ACTH antibody in ovine pituitaries, confirming the specificity of ACTH immunostaining (Farrand et al., 2006) . Furthermore, to confirm the specificity of the fluorophore-conjugated secondary antibodies, separate sections incubated with each primary antibody were then incubated with inappropriate secondary antibodies to detect any bound fluorescence.
Epifluorescent imaging of pituitary cells
Immunohistochemical staining was visualized using an AX70 epifluorescent microscope (Olympus, Tokyo, Japan) connected to a digital camera (Photometrics 
Quantification
Extensive quantification (more than 120,000 cells per animal group) was determined using the image analysis software, analySIS (Soft Imaging Systems, Munster, Germany) (Farrand et al., 2006) . For each photographed field, the total number of nuclei, identified by DAPI, and the number of cells immunopositive for each antigen were identified using a mechanical threshold function that establishes a window of optical density values equating to unequivocal positive staining. The number of nuclei and immunopositive cells in all sections were totaled for each animal per treatment. Results from the six animals per treatment group were compared as described below. For each antigen, the accuracy of the automated quantification method was validated against manual cell counts, whereby the total number of nuclei and immunopositive cells in five non-overlapping fields were assessed.
Statistical analysis
Corticotrophs, somatotrophs, lactotrophs, thyrotrophs and gonadotrophs were defined as any pituitary cell immunopositive for ACTH, GH, PRL, TSH and LH (or sets were determined to be normally distributed by Kolmogorov-Smirnov test, after which analyses for significance of effects by age and HPD were assessed by one-way ANOVA. Where ANOVA indicated a significant effect, differences among groups were assessed using Tukey's Test post-hoc (Dythan, 2003) . Differences were considered statistically significant at P values less than 0.05.
Results
Specificity of immunostaining
The immunohistochemistry provided clear and specific staining of cells for the various AP hormones and nuclei. ACTH, PRL, GH, TSHβ, LHβ and FSHβ were localized to the cytoplasm of specific pituitary cells (Fig. 1) . Staining was not observed for any of these peptides in the neural lobe. Cells within the intermediate lobe stained positively for ACTH in the same proportion as found in an earlier study (Farrand et al., 2006) . Preabsorption of ACTH, GH, PRL, TSHβ and LHβ antisera with corresponding peptides completely abolished immunostaining, as previously shown (Farrand et al, 2006; Schwartz et al., 1999) . No staining was present when normal donkey serum was substituted for each of the primary antibodies (data not shown). Positive signals were only observed when the optic cube appropriate for each fluorophore was used, and no spectral bleed through was evident. Additionally, there were no readily identifiable contiguous concentrations of the various cell types.
Effects of ontogeny and HPD on pituitary cell development
Pituitary cells identified as corticotrophs, somatotrophs and lactotrophs could be all detected at 110-141 d gestation. Despite the likely increase in the total number of AP cells over this period, there was no significant effect of gestational age on the proportion of corticotrophs and somatotrophs (Fig. 2) . In contrast, the proportion of lactotrophs effectively doubled between 110-141 d gestation (Fig. 2) . Thus, from 110-141 d gestation corticotrophs and somatotrophs increased in proportion to overall pituitary growth, whereas the proportion of lactotrophs increased disproportionately.
Pituitary cells identified as thyrotrophs and gonadotrophs could be all detected at 110 and 141 d gestation. There was no significant change in the relative proportion of thyrotrophs between 110-141 d gestation (Fig. 2) . In contrast, there was a marked increase (P<0.05) in the proportion of gonadotrophs, defined as expressing either LH or FSH. The proportion of cells expressing LH increased by approximately half between 110-141 d gestation (Fig. 2) . The increase in the proportion of cells staining positive for FSH over the same period is even more dramatic (Fig. 2) .
There was no significant difference in the proportion of corticotrophs, 
Removal of hypothalamic input from the pituitary
The greater proportion of thyrotrophs observed in HPD foetal pituitaries at 141 d gestation suggests that hypothalamic input exerts a modulatory influence on thyrotroph development in the foetus during late gestation. Previous findings in TRH-null mice (Shibusawa et al., 2000) suggest that TRH is not required for thyrotroph development, and the present results would support the concept that positive influence from the hypothalamus is not required for increases in TSH-containing cells. HPD removes all hypothalamic factors from the pituitary and the present data are consistent with net inhibitory hypothalamic influence on TSH cells during development. A study in another model of development, foetal rats following encephalectomy, resulted in no change in numbers of thyrotrophs. (Begeot et al., 1981) . Although the reasons for discrepant results between HPD and encephalectomy studies are unknown, encephalectomy would clearly involve gestational adaptation and not simply isolation of the AP from the hypothalamus.
With respect to HPD, it should also be remembered that this procedure might also be expected to alter feedback on the AP from peripheral target organs. In the case of the hypothalamo-pituitary-thyroid axis, diminished TRH drive would ultimately be expected to result in decreased secretion of thyroid hormones. It is possible that lower feedback inhibition at the pituitary might influence the differentiation/proliferation of thyrotrophs, and this possibility cannot be ignored.
It has been proposed that there is an absolute requirement for gonadotropinreleasing hormone input to gonadotrophs for the maintenance of gonadotrophs, at least in the adult animal (Childs, 1997) . On that basis, one would expect there to be a reduction in In the present study, when we examined co-localization of FSH and LH (i.e FSH-LH cells) we found that FSH and LH are co-expressed in many cells. This is consistent with earlier reports of co-expressing gonadotrophs such as observed in the juvenile and adult male rhesus monkey (Meeran et al., 2003) . We showed that there is a substantial, persistent population of gonadotrophs that express LH-only (i.e cells LH+/FSH-) and, in contrast to other gonadotrophs these cells are unaltered by HPD.
Together, these data suggest that although some gonadotrophs may develop in the absence of hypothalamic input, achieving a full complement of gonadotrophs that coexpress both gonadotrophins requires hypothalamic signaling. Thus, it is possible that during late gestation, gonadotroph development may be, in part, dependent on hypothalamic input, or at least hypothalamic influence may be maintaining this cell type.
Another unexpected finding is that the substantial proportion of gonadotrophs that only express LH also appears to be unaltered by age, unlike FSH-LH cells. This suggests independent regulation of subpopulations of LH-expressing cells and warrants further investigation.
As our single-label immunostaining clearly showed an opposite effect of comparable magnitude of HPD on the proportion of LH and TSH expressing cells, we examined hypothalamic influence on their co-localization. We hypothesized that during foetal development there might be a population of cells capable of producing glycoprotein hormones, the determination of which is produced being dictated by the hypothalamus. We found that dual-labeled TSH-LH immunopositive cells were extremely rare (<1%) in all groups we studied. In contrast to the present study in foetal sheep, previous work has shown co-localization of TSH with LH in the mouse (Nunez et The relative proportions of corticotrophs were neither altered by age or HPD, suggesting either independence from hypothalamic input (Timpl et al., 1998) or that it is required before 110 d gestation. In support of this, it has been shown that expression of ACTH is apparent before the formation of Rathke's pouch (Kouki et al., 2001 ). The absence of any significant change in the proportion of corticotrophs over the time period of the present study is consistent with some previous observations (Matthews et al., 1994 ), but not others in which increases (Braems et al., 1996) 
